Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Higher Than Its 50 Day Moving AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prev… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Higher Than Its 50 Day Moving AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prev… Continue reading
Washington Post |
A cancer patient desperately needs a stem–cell transplant. But the US won’t grant the donor a visa.
Washington Post Doctors told Helen’s family the patient needed a life-saving stem cell transplant. The procedure required as close of a genetic match to Helen as possible. Her three sisters — all living in Vietnam — were the best bet. Doctors could proceed if they … |
|
STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX, an Innovation …
Business Wire (press release) VANCOUVER, British Columbia–(BUSINESS WIRE)–STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables … |
Technology Networks |
Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences
Technology Networks The use of Synpromics’ synthetic promoters will enable the enhancement of Solid Biosciences’ investigational gene therapy candidates for the treatment of DMD. These muscle-selective promoters have been designed using Synpromics’ PromPT® technology … |